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Background: More older people are living in the community with multiple diagnoses and medications. Managing
multiple medications produces issues of unrivalled complexity for those involved. Despite increasing literature on
the subject, gaps remain in understanding how, why and for whom complex medication management works, and
therefore how best to improve practice and outcomes. MEMORABLE, MEdication Management in Older people:
Realist Approaches Based on Literature and Evaluation, aimed to address these gaps.
Methods: MEMORABLE used realism to understand causal paths within medication management. Informed by
RAMESES (Realist And Meta-narrative Evidence Synthesis: and Evolving Standards) guidelines, MEMORABLE involved
three overlapping work packages: 1) Realist Review of the literature (24 articles on medication management
exploring causality); 2) Realist Evaluation (50 realist-informed interviews with older people, family carers and health
and care practitioners, explaining their experiences); and 3) data synthesis and theorising from 1) and 2).
Results: Medication management was viewed from the perspective of ‘implementation’ and structured into five stages:
identifying a problem (Stage 1), getting a diagnosis and/or medications (Stage 2), starting, changing or stopping
medications (Stage 3), continuing to take medications (Stage 4), and reviewing/reconciling medications (Stage 5).
Three individual stages (1, 3 and 4) are conducted by the older person sometimes with family carer support when they
balance routines, coping and risk. Stages 2 and 5 are interpersonal where the older person works with a practitioner-
prescriber-reviewer, perhaps with carer involvement.
Applying Normalisation Process Theory, four steps were identified within each stage: 1) sense making: information, clarification; 2)
action: shared-decision-making; 3) reflection/monitoring; and 4) enduring relationships, based on collaboration and mutual trust.
In a detailed analysis of Stage 5: Reviewing/reconciling medications, adopting the lens of ‘burden’, MEMORABLE identified five
burdens amenable to mitigation: ambiguity, concealment, unfamiliarity, fragmentation and exclusion. Two initial improvement
propositions were identified for further research: a risk screening tool and individualised information.
Conclusions: Older people and family carers often find medication management challenging and burdensome particularly for
complex regimens. Practitioners need to be aware of this potential challenge, and work with older people and their carers to
minimise the burden associated with medication management.
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Rationale for the research
The number and proportion of older people in the
United Kingdom population continues to increase [1–4],
as does multi-morbidity and polypharmacy amongst
them [5–7]. This reflects global trends [8]. Multi-
morbidity (two or more long term conditions) and
polypharmacy (five or more medications or, if less, a
complex regime) are inherently complex and challenging
to manage [9, 10].
For older people, living with multi-morbidity and poly-
pharmacy can be burdensome [11–15] and may signifi-
cantly reduce their quality of life [4, 11, 13–18].
Polypharmacy is associated with an increase in drug re-
lated adverse events and non-adherence [19–21], both of
which can be costly for health services [22–24]. Informal
or family carers who support older people find that help-
ing them with complex medication management can be
an onerous responsibility [1, 25]. Practitioners, many of
whom continue to work with models of illness or in ser-
vices that are tailored to acute treatment [17, 26], face a
growing workload as this population of older people and
their family carers require sustained management and
support [5, 7, 10, 16, 26]. Practitioners also encounter
additional stresses from time and financial pressures, a
decline in workforce numbers, as well as the re-
organisation of health and care amid changing financial
and political circumstances [27–29]. Structural and op-
erational problems persist despite the need for extended,
co-ordinated management that supports older people
living with multiple long term conditions [26, 30, 31].
Delivery of older people’s health and care appears to be
fragmented [4]. NHS England recently launched the Na-
tional Health Service Long Term Plan to address many
of these long standing strategic issues [32, 33].
Current medication management policy, guidelines
and interventions in the United Kingdom are predomin-
antly practice and performance-orientated. They are
underpinned by two key approaches: adherence, ‘the ex-
tent to which the patient’s action matches the agreed
recommendations’ [19] and optimisation, ‘a person-
centred approach to safe and effective medicines use, to
ensure people obtain the best possible outcomes from
their medicines’ [34, 35]. In this project, MEMORABLE
(MEdication Management in Older people: Realist Ap-
proaches Based on Literature and Evaluation), the term
‘medication management’ has been used to encompassthe complexity of practices and behaviours in which per-
formance requirements are integrated with older peo-
ple’s experiences of living with several diagnoses and
complex medication regimes. The term acknowledges
that medication management is only part of, but con-
tributes to, the full richness and quality of old people’s
day-to-day lives.
Despite clarity on many issues surrounding medication
management and older people in research, studies fre-
quently adopt a linear, logic model perspective [36],
geared to adherence and optimisation for which a behav-
ioural approach is often advocated. These studies have
clarified many of the issues surrounding medication
management and older people. However, achieving ad-
herence and optimisation continue to be problematic.
Many studies adopt a linear, logic model perspective
[36] to describe the factors associated with an interven-
tion. However, they do not identify explanatory mecha-
nisms operating between those factors that would better
reflect real world, day-to-day complexity, encompassing
the many iterative and causal processes geared to the
achievement of meaningful outcomes [15, 37]. Such an
explanatory approach underpins this research and there-
fore the potential utility of findings.
Focus of the research
MEMORABLE aimed to explain medication manage-
ment from this wider perspective. A realist approach
was chosen because it enabled the researchers to work
with complexity and understand how medication man-
agement works in the real world [38–45]. Systematic re-
views examine an ‘averaging’ effect whereas realist
reviews explore contexts where particular mechanisms
are most likely and least likely to occur. Realism specific-
ally aims to explain how, why and for whom complex in-
terventions such as medication management work, or
not i.e. to provide explanations for the causes of phe-
nomena that take into account the influence of context
impacting at the individual level. This contrasts with
clinical trials that investigate and control selected causal
factors to identify effects at a population level.
Medication management was scoped as an extended,
complex process rather than a single intervention, using
realist methodology to understand how that process
might work. Secondary data from a realist review were
combined with primary data from a realist evaluation. A
theory-informed and causally-structured evidence and
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and improve medication management, and develop
novel multidisciplinary, multi-agency interventions.Methods
Overview
MEMORABLE involved theorising about the interven-
tion by generating and refining programme theory, and
testing with data to explain underlying causal processes,
the contexts, mechanisms and outcomes within an inter-
vention, to identify what works, for whom, why and in
which circumstances [42, 43]. Causal explanations at in-
dividual, group and organisational levels account for the
influence of contexts on outcomes. By facilitating the
understanding of medication management as a complex
intervention, realist methodology aligned well with
MEMORABLE’s aims and objectives.
Described in detail in the published protocol [46],
MEMORABLE involved three overlapping Work Pack-
ages, involving seven, iterative steps: see Fig. 1. The
Work Packages and their methods are outlined below in
brief:
 Work Package 1: Realist Review – Steps 1–4;
 Work Package 2: Realist Evaluation – Step 5;Fig. 1 Research Process Summary: Work Packages and Steps(Iterations of Work Packages 1 and 2: Steps 3a and
b, 4a and 5a and b); and
 Work Package 3: Data synthesis – Steps 6–7.
Work package 1: realist review
The research began with an exploration of the scope of
medication management, by setting out initial
programme theories about how it might work. A prelim-
inary systematic literature search was then undertaken:
published articles in the English language, 2009–2018,
using terms for ‘medication management’, ‘older people’
and ‘long term conditions’ (see Additional File 1). As
more than 1000 articles were identified, a further search
focussed on the identification of explanatory data in
these articles by using specific causal terms: ‘concept’,
‘framework’, ‘model’ and ‘theory’.
Following a realist logic of analysis, patterns of factors
identified for their explanatory potential were extracted
from the articles and mapped onto a spreadsheet. Quali-
tative data analysis software (NVivo) facilitated data ab-
straction and analytical iterations to draft and refine
emerging context, mechanism, outcome (CMO) configu-
rations, largely based on interpretations of the data.
As the research progressed, additional searches were
carried out on emerging topics of interest, such as
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search on substantive theory: Normalisation Process
Theory [47]. NPT was specifically chosen for its imple-
mentation focus because it articulates the way new prac-
tices or activities (for example in relation to medication)
are introduced and are made routine or sustained
through the work that is done by those involved.
Work package 2: realist evaluation
50 realist-informed interviews were conducted: older
people (n = 13), over the age of 60 years, living in the com-
munity with multi-morbidity and polypharmacy and in-
cluding two older people living with mild dementia
amongst other diagnoses; family carers (n = 16) including
seven family carers of older people living with dementia
and other conditions; and health and care practitioners
(n = 21). Practitioners included managers and front line
staff involved in medication management such as geriatri-
cians, general practitioners, nurses, pharmacists and phar-
macy technicians, a social worker, care managers and
formal carers. Interviewees were identified through foun-
dation trusts, primary care practices and Join Dementia
Research, as well as practitioner and personal contacts.
Participant involvement necessitated approval by the
research sponsor, Aston University, a regional Research
Ethics Committee by Proportionate Review and the
Health Research Authority (approval issued 26th Sep-
tember 2017: REC reference: 17/EE/3057).
Hour long interviews followed a realist-informed
schedule to ensure consistency but also the flexibility to
explore descriptive and causal accounts as they emerged.
Following the same realist logic of analysis, interviewee
data describing and explaining how medication manage-
ment worked for them, day-to-day, were analysed at the
level of individual and collective narratives as well as for
the underpinning CMO configurations, as in Work
Package 1. As the number of interviews analysed this
way increased, more robust and detailed patterns of
CMO’s emerged directly from these more focused, ex-
periential, causal accounts.
Work package 3: data synthesis
CMO’s from the literature were synthesised with CMO’s
from the interviews, identifying consistent patterns
across both data sets as well as other CMO’s of interest
because of their explanatory potential. Robust causal ac-
counts elicited from those directly involved in medica-
tion management supported revisions to CMO’s
generated from the literature where causal links were
often lacking. Emerging findings were debated by the
Research Team and further iterations of analysis under-
taken to revise, refine or reject CMO’s. Generating these
increasingly refined causal accounts across both data sets
enhanced understanding of the scope of the medicationmanagement process as a whole. Also, with the benefit
of a number of CMO’s combining both evidence and ex-
periential data, this enabled progressive revision of the
initial programme theories from which interventions
were proposed. However, because of the quantity and
quality of data generated for the whole medication man-
agement process, and finite time and funding for the re-
search, the researchers needed to concentrate
exploration on areas most likely to yield substantial
causal explanations as the basis for improvement pro-
posals. Stage 5: Reviewing/reconciling medication was
chosen because it was a well-documented, interpersonal
stage, where practitioners had an opportunity to influ-
ence what might happen in other stages.
Normalisation Process Theory [47, 48], adapted
through the work of Gallagher et al. [49], was applied to
the analysis of Stage 5 because it provided concepts that
explained the underpinning steps older people and
others involved in their care go through to introduce
and sustain medication routines, such as sense making
and relationships. These steps were mapped across the
work on stages, including Stage 5. Thus, this substantive
theory augmented the granularity of data analysis, en-
hancing the drafting and refining of CMO’s.
Final revisions to MEMORABLE’s programme theory
were set out in an explanatory framework from which
interventions were proposed.Results
Section overview
This section reports the progressive analysis of the lit-
erature and interviews, from foundational work on un-
derstanding the complexity of medication management
to the generation of burden-centred programme theory.
It begins with the realist review, augmenting the descrip-
tion of medication management before setting out initial
CMO configurations. Findings from the realist evalu-
ation are reported next, highlighting interviewee’s expe-
riences of tasks, routines and outcomes, followed by
CMO configurations based on their accounts. Finally,
the data synthesis reports the combined analysis of the
data sets, addressing the complexity of the medication
management process through a five stage, four step,
three-loop structure. Informed by Normalisation Process
Theory and viewed through the lens of ‘burden’, five
burdens were identified from the analysis of CMO con-
figurations for Stage 5: Reviewing/reconciling medica-
tion. The progressive focussing of analysis in a realist
approach was fundamental to the generation of MEMO-
RABLE’s theoretical framework, concluding this section.
Despite the linear way in which these findings are pre-
sented, analysis involved numerous iterations to address
the complexity of the topic, refine the scope and
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burden within it.
Realist review findings: understanding the breadth of
medication management (work package 1)
Literature on the complexity of medication management
Medication management aligns with the Medical Re-
search Council criteria as a complex intervention [50].
The review screening processes reduced the initial
returned articles from 1018 to 24: see Fig. 2 [51]. These
24 articles (from 2009 to 2017), were selected for final
analysis being judged as most likely to contain the
relevant data needed to build an initial programme
theory of medication management. In other words they
contained data on: ‘concept’ (n = 4) [52–55]; ‘framework’
(n = 5) [56–60]; ‘model’ (n = 9) [61–69]; or ‘theory’
(n = 6) [70–75]. Table 1 sets out details of these
documents.Fig. 2 PRISMA Flow Diagram: medication management: developed from MPotentially significant factors but limited causal links
were identified in the medication management literature.
These factors included the importance of older people’s
medication management workload [17, 18, 56], highlight-
ing the influence of diagnoses, symptoms and illness trajec-
tories that overlay ageing processes [11–13, 55]; the
medications they take, including high risk drugs, doses and
complex regimes [7, 10, 20, 56]; and relationships with pre-
scribers [56, 58, 60]. Without explaining how, these factors
were believed to contribute to behavioural responses such
as self-efficacy, coping styles and control: ‘personalised,
contingent and contextually situated … highly individua-
lised routines and strategies’ [52]. Tentative links between
‘the overburdened patient’, poorer adherence and worse
outcomes began to emerge [13–15, 76–81].
The role of doctors [52, 54, 56], and increasingly phar-
macists [57, 59, 61] and nurses [52, 56], was central to
prescribing [53, 55, 56], de-prescribing [53, 59] andoher et al. [51]
Table 1 Medication management articles with the terms concept, framework, model or theory
Authors Title Year Country Topic Method
Concept (n = 4)
Cheragi-Sohi,
S., Jeffries, M.,
Stevenson, F.
et al. [52]
The influence of personal
communities on the self-
management of medication tak-
ing: A wider exploration of medi-
cation work
2015 UK Personal communities
involved in medication
work
Semi-structured
interviews and the
construction of Network
Diagrams
Fried, T.R.,
Niehoff, K., Tjia,
J. et al. [53]
A Delphi process to address
medication appropriateness for
older persons with multiple
chronic conditions
2016 USA Translating framework
concepts into specific
strategies to identify and
remediate inappropriate
regimes, focusing on de-
prescribing to reduce
medication burden
Modified Delphi process:
3 rounds of anonymised
web-based surveys
Naik, A.D.,
Dyer, C.B.,
Kunik, M.E.
et al. [54]
Patient Autonomy for the
Management of Chronic
Conditions: A Two-Component Re-
conceptualisation
2009 USA Autonomy: decisional
(about treatment) and
executive (carry treatment
plan out) in the context
of multiple conditions
Concept development
Upadhayay, J.
and Joshi, Y
[55].
Observation of drug utilisation
pattern and prevalence of
diseases of elderly patients
through home medication review
2011 India Medication review by
pharmacists
Community-based survey
Framework (n = 5)
Bartlett-Ellis,
R.J. and Welch,
J.L.* [56]
Medication-behaviours in chronic
kidney disease with multiple
chronic conditions: a meta-
ethnographic synthesis of qualita-
tive studies
2016 Australia,
England,
USA
Medication taking and
medication adherence
behaviours
Qualitative study review
Boskovic, J.,
Mestrovic, A.
Leppee, M.
et al. [57]
Pharmacist competencies and
impact of pharmacist intervention
on medication adherence: an
observational study
2016 Croatia Results of pharmacists
intervention on adherence
in the community
Observational study
Coleman, A
[58].
Medication Adherence of Elderly
Citizens in Retirement Homes
through a Mobile Phone
Adherence Monitoring Framework
(Mpamf) for Developing
Countries: A Case Study in South
Africa
2014 South
Africa
Intervention development:
technology
Case Study with
qualitative interviews
Schuling, J.,
Gebben, H.,
Veehof, L.J.G.
and Haaijer-
Ruskamp, F.M
[59].
De-prescribing medication in very
elderly patients with multi-
morbidity: the view of Dutch GP’s.
A qualitative study
2012 Netherlands Exploring experienced GPs’
views on de-prescribing
and involving older people
in these decisions
Qualitative study
Yap, A.F.,
Thirumoorthy,
T. and Kwan,
Y.H [60].
Medication adherence in the
elderly
2015 Singapore Systematic review of the
barriers to adherence in
the elderly
Case study
Model (n = 9)
Doucette, W.R.,
Vinel, S. and
Pennathur, P.*
[61]
Initial development of the
Systems Approach to Home
Medication Management
(SAHMM) model
2017 USA Systems approach to safe
and effective home
medication management
Model development
Hennessey, B.
and Suter, P
[62].
The Community-Based Transitions
Model: One Agency’s Experience
2011 USA The acquisition and use of
health coaching competencies
in home care clinicians at
health transitions
Model development
Jonikas, M.A.
and Mandl, K.D
Surveillance of medication use:
early identification of poor
2011 USA Identification of population
level adherence and risk
Model development
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Table 1 Medication management articles with the terms concept, framework, model or theory (Continued)
Authors Title Year Country Topic Method
[63]. adherence of poor adherence
Khabala, K.B.,
Edwards, J.K.,
Baruani, B.
et al. [64]
Medication Adherence Clubs: a
potential solution to managing
large numbers of stable patients
with multiple chronic diseases in
informal settlements
2015 Kenya Assessment of the people’s
care through nurse facilitated
Medication Adherence Clubs
Retrospective
descriptive study
Kucukarslan,
S.N., Lewis,
N.J.W., Shimp,
L.A. et al.* [65]
Exploring patient experiences
with prescription medicines to
identify unmet patient needs:
Implications for research and
practice
2012 Canada,
USA
Identification and characterisation
of patients’ unmet needs when
taking prescribed medication
Grounded theory
approach to
interview content
analysis
McHorney,
C.A., Zhang,
N.J., Stump, T.
et al.* [66]
Structural equation modelling of
the proximal distal continuum of
adherence drivers
2012 USA Identification of adherence drivers Model development
Lau, Y., Htun,
T.P., Chan, K.S.
and Klainin-
Yobas, P [67].
Multidimensional factors affecting
medication adherence among
community-dwelling older adults:
a structural-equation modelling
approach
2017 China Multidimensional factors affecting
medication adherence: measuring
medication adherence,
professional-help relationship and
self-care abilities
Exploratory cross-
sectional approach
using interviews
and modelling
Milani, R.V. and
Lavie, C.J [68].
Health Care 2020: Reengineering
Health Care Delivery to Combat
Chronic Disease
2015 USA Modifying the healthcare delivery
model to include team-based care
in concert with patient-centred
technologies
Review
Shepherd, J.G.,
Locke, E.,
Zhang, Q. and
Maihafer, G
[69].
Health Services Use and
Prescription Access Among
Uninsured Patients Managing
Chronic Diseases
2014 USA Identification of relationships
between population characteristics,
health behaviour and outcomes
Longitudinal quasi-
experimental design
with convenience
sample for assessment
and notes review
Theory (n = 6)
Geryk, L.L.,
Blalock, S.J.,
DeVellis, R.F.
et al. [70]
Medication Self-management Be-
haviors among Arthritis Patients:
Does Attentional Coping Style
Matter?
2016 USA Coping styles Internet based survey
Haslbeck, J.W.
and Schaeffer,
D [71].
Routines in medication
management: the perspective of
people with chronic conditions
2009 Germany Routines in medication
management along
chronic illness trajectory
Semi structured
interviews: initial
and follow up
Laba, T-L.,
Lehnbom, E.,
Brien, J. and
Jan, S [72].
Understanding if, how and why
non-adherent decisions are made
in an Australian community sam-
ple: A key to sustaining medica-
tion adherence in chronic disease?
2015 Australia Intentional non-adherent
decisions and behaviours
Semi-structured
interviews and
theory-informed
iterative thematic
framework analysis
Marks, R [73]. Self-efficacy and arthritis
disability: An updated synthesis of
the evidence base and its
relevance to optimal patient care
2014 n/a Self-efficacy, pain and
disability, adherence to
therapeutic strategies
and outcomes, applicable
to assessment and treatment
Review and synthesis
Oliveira, C.,
Helena, J. and
Castro-Caldas,
A [74].
Interventions to Improve
Medication Adherence in Aged
People with Chronic Disease –
Systemic Review
2017 USA, China,
Portugal,
Italy
Nursing interventions to
improve medication adherence
in older people with chronic
disease
Systematic Review
Skolasky, R.L.,
Green, A.F.,
Scharfstein, D.
et al. [75]
Psychometric Properties of the
Patient Activation Measure among
Multimorbid Older Adults
2011 USA Patient Activation Measure
(Hibbard): Psychometric
properties and model
evaluation
Interviews + completion
of Measure. Cross-
Sectional and latent class analysis
*Articles containing more than one of the search terms
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lationships [54, 56, 65] were valued for their continuity [82],
addressing service and organisational fragmentation [5].
Shared decision making [83–88] was increasingly recognised
for the way it enhanced practitioner contacts [9, 34,
89]; this included involving family carers of older
people living with dementia [90, 91]. In these circum-
stances, practitioners appeared more likely to be able
to influence older people’s ‘decision architecture’ [92]
and therefore what they did at home: ‘enhanc(ing)
self-management capacity regarding medication use’
[67].
Initial theorising about medication management: setting
out preliminary CMO configurations
Semi-structured patterns of causal factors were ab-
stracted from these 24 articles and mapped as prelimin-
ary CMO configurations; 10 in total. Examples include
the way that polypharmacy increases the risk of adverse
drug events through the physiology of ageing (Lit CMO
01); medication adherence is increased when control is
given to carers (Lit CMO 02); and adherence to disease
specific guidelines increases polypharmacy when practi-
tioners follow evidence-based rather than person-centred
practice (Lit CMO 03).
Realist evaluation findings: increasing the focus on
implementation and causality (work package 2)
Experiences of medication management: tasks, routines and
outcomes
50 interviewees described and then explained their expe-
riences of medication management: see Table 2 for
interviewee characteristics.
Analysis validated and extended the results of the review,
augmenting the understanding of implementation. Key
areas found during analyses were: first, the diverse range ofTable 2 Interviewee characteristics
Group Number Male/
female
Age rang
mean
Older people 60 years+, multi-morbidity,
polypharmacy
13 7/6 60–84/ 7
Family carers 16 5/11 N/A
Practitioners (health and care) 21 N/A N/Apurposeful implementation work, day-to-day tasks and rou-
tines interviewees were involved in; and second, outcomes
that interviewees identified as important to them.
First, interviewees described their workload, potentially
burdensome, including:
 older people: making and attending appointments,
including organising travel to and from surgeries
and hospitals; arranging blood and other tests, and
following up results; getting a prescription and
having it filled at a local pharmacy; sorting tablets
into daily, weekly or monthly containers and
typically locating containers in the kitchen to
prompt them about tablets that go with food;
following a flexible medication management routine
to fit with day-to-day life and unexpected events;
 family carers: providing physical assistance with
appointments, collecting or taking medications;
providing cognitive support to ensure medications
are taken, ensuring prescriber recommendations
followed and sufficient supplies maintained;
encouraging and advocating for their family
member; and
 practitioners (role-performance based): formal
carers adhering to local policies and individual care
plans for prompting or administering, and reporting
medication-taking; a social worker assessing self-
medication skills and using Care and Support Plan-
ning to meet changing levels of need; general practi-
tioners presenting treatment options to engage older
people in decision-making about medication and
checking adherence; geriatricians/acute teams get-
ting accurate, timely medication lists on admission
and providing revised lists on discharge; nurses and
pharmacists carrying out reviews based on a single
diagnosis or medication.e / Practitioner roles
3
Doctors: 2 consultant geriatricians, 2 general practitioners.
Nurses: 5: including a nurse manager, specialist nurses,
community matrons.
Pharmacy staff: 3: head of service, clinical pharmacist, pharmacy
technician.
Social worker: 1
Care providers: 7: including managers, assessors, team leaders
and front-line staff.
Strategic manager (health and care): 1
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sociated with medication management that mattered
to them and were potentially motivating, including:
 older person: “I can be normal and go out and do
things and play with our grandson and cook meals
and live a life.” (OP5);
 family carer: “I want them to keep his condition
steady … I can cope with that … and being safe.”
(C14); and
 general practitioner: “The patient still needs and is
benefiting from that medication … hopefully doing
more good than it is harm … based on current
guidance … cost-effective, in terms of a brand or gen-
eric prescribing … the patient has the ability to, kind
of, understand why they are taking it.” (P25).
Further theorising about medication management:
validating and extending CMO configurations
Forty-nine CMOs were developed based on the inter-
views: 17 CMOs were generated from older people’s in-
terviews, 16 from family carers’ and 16 from
practitioners’ accounts. Examples include how older
people access healthcare when they think their health or
medication is disrupting day-to-day lives and independ-
ence, so they regain control (OP CMO 01); family carers
increasingly getting involved when they identify health
and care problems or gaps, by responding to what is
needed (C CMO 3); and how practitioner consistency
enables older people to improve the way they manage
complexity and risk when dealing with several long term
conditions (P CMO 16).
Data synthesis: moving towards an understanding of
burdens in medication management
Further analysis aimed at bringing together both datasets
in order to develop a coherent understanding of medica-
tion management and culminated in the following key
explanatory findings.
Medication management: identifying five stages and loops
between them
Medication management was refined into five functional
stages: (for more information see Additional File 3).
 Stage 1: Identifying a problem.
 Stage 2: Getting a diagnosis and/or medications.
 Stage 3: Starting, changing or stopping
medications.
 Stage 4: Continuing to take medications.
 Stage 5: Reviewing/reconciling medications.
These stages reflect how an older person or their fam-
ily carer might recognise a health change, perhaps a newsymptom (Stage 1) for which they consult a health prac-
titioner (Stage 2). Issued with medication, they then start
their new tablets (Stage 3), making them part of their
day-to day routine and continuing with their medica-
tions (Stage 4), subject to regular review (Stage 5).
Within such an apparently simple scenario, interview
data was invaluable in identifying ‘hidden’, dynamic iter-
ations and loops across stages (see Additional File 3 for
further details).
Interview data also helped to better understand inter-
viewees’ workload and burdens:
 older people: the importance of routines and fit
with day-to-day life that are indicative of coping
with burden, particularly when continuing to take
medications in Stage 4; the value attributed to
enduring, mutually trusting relationships in Stages 2
and 5; and how practitioner-initiated changes
reverberate through existing routines and coping,
impacting on initiation work (Stage 3) and sustaining
work (Stage 4), with associated emotional, cognitive
or behavioural disruptions or loops;
 family carers: the stress and risks of their
ambiguous ‘informal’ role, evolving and infiltrating
all stages, and the lack of training and support they
receive. This contrasts with formal carers working
under contract, who are trained, supervised and
managed to undertake the same, and sometimes
more limited, medication management tasks; and
 practitioners: the way Stage 5 can loop back to Stage
2 for further diagnostic work or to Stage 3 where
medications are changed: See Additional File 3, and
the complexity inherent in their formal medication
management work to diagnose, prescribe and review
in Stages 2 and 5, transacted in time-limited,
influential contacts. Health and care practitioners
acknowledged increases in caseloads and more
complex cases, as well as performance and delivery
pressures.
Medication management: identifying four steps in each
stage
Interview data were also key to exposing another ‘hid-
den’ aspect of the medication management process; initi-
ating and sustaining work within one or more of the five
stages, interpreted through and adapted from Normal-
isation Process Theory [47, 49]:
 sense making: finding meaning in events, artefacts
or relationships: ‘coherence work’ [47]:
 older person: “I don’t think it’s difficult … I quite
understand a lot of my drugs as well which helps …
interested in the drugs, in what they do and what
they’re for … I read the leaflets, yes.” (OP19);
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continuity: ‘relational work’ [47]:
 practitioner – general practitioner: “In terms of
decision making, you’re the person best placed to
make decisions, if you would recognise things that
another clinician might not … what this person’s
normally like or how they normally would present …
situations where we’ve been here before … if you’ve
seen that person a lot you’ll remember that and
you’ll remember how you managed it last time. And
the medical records don’t give the story.” (P53).
 action: doing tasks: ‘operational work’ [47]:
 older person, living with mild dementia: “I know
what medication I get, I know that I can get it
collected every month, and I’m the one who sticks it
in the boxes so I know when to take it … I think the
process is important and the routine is important –
that’s the key bit really.” (OP10); and
 reflection / monitoring: thinking about what
happened and its effect / recording and reporting
impact: ‘appraisal work’ [47]:
 reflection:
 family carer: "I’ve walked out of the
appointments feeling really sad, thinking “I’m
really angry with the way I’ve been treated and
the fact that I let it go.” (C15);
 monitoring:
 practitioner – pharmacist: “We’d follow NICE
guidance with a view to what medication our elderly
patients should be on … an area prescribing
formulary as well … evidence as to why we have
done something.” (P1).
These steps highlight important processes that underpin
behaviours around health and medication, as well as
pointing to key individual characteristics and capacities.
Thus, in managing their medication and interacting with
practitioners, some older people or family carers have cap-
acity to respond and be motivated by information-giving
and trust- or confidence-building strategies that impact a
sense of control, while others are more action focused. Di-
minished capacity in any of these steps might lead to be-
ing overburdened and not coping with the workload.Theorising on Stage 5 and burden: focused analysis of CMO
configurations
Theorising on Stage 5: From the 59 CMO configura-
tions generated by the analysis, four CMOs from the lit-
erature directly related to practice-performance in Stage
5: Reviewing / reconciling medications:
 When practitioners carry out a medication review
using an evidence-based review tool (C), they aremore likely to identify and discontinue high risk
medications and simplify regimes (O) because they
are confident making decisions (M) (Lit CMO 04);
 Regular medication reviews and transition
reconciliations by experienced practitioners (C),
optimises medication management (O), by
minimising the risk of treatment related problems
(M) (Lit CMO 05);
 When practitioners carry out a medication review
in an older person’s home (C), they are more
likely to identify medication related problems (O),
because they understand people’s lived experiences
and they take more time (M) (Lit CMO 06); and
 Pharmacists carrying out a home medication
review (C) are more likely to identify and resolve
medication related problems (O), because of their
particular expertise and experience (M) (Lit CMO
07).
Additional, more generalisable CMOs were also found
to apply to this stage, such as:
 Practitioners, older people, informal carers are likely
to make better decisions about medication (O),
strengthen their relationships (O) and achieve
continuity of care (O), when they collaborate
through shared decision making (C), because of
mutual trust (M) (Lit CMO 08); and
 Information technology used by older people,
informal carers and practitioners (C) improves
access, information sharing and support (O) by
reinforcing communication (M) (Lit CMO 09).
Burden: burden was identified as a potential key topic
early in MEMORABLE and confirmed as the research
progressed, linked to medication management workload
and capacity [13, 15, 49, 79]. The researchers established
links between concepts of burden, coping and risk, illus-
trated in Table 3, highlighting a possible burden-coping
dynamic and risk association with increasing/high or de-
creasing/low workload and capacity. The lens of burden
was applied to this part of the research.
Burden was a key concern, such as when older people
and family carers described multiple health and care
contacts for reviews across different sites, services, teams
and practitioners, and the time and effort involved (OP
CMO 15). Here the workload involved getting to, and
participating in a review at their practice or at a
pharmacy; having to visit a phlebotomist for blood
tests at their local practice or hospital prior to their
review; and seeing a doctor, nurse or pharmacist for
the actual review but their doctor or hospital consult-
ant for follow-up. The researchers also identified
other hidden burdens, applicable to this stage, where
Table 3 Burden, coping and risk in medication management
What capacity does the older person have? (individual specific)
What is the workload? (stage specific)
Increasing / high
capacity
Decreasing / low capacity
Increasing / high workload: May be high workload per se or may spike at
times of change and uncertainty.
Burden: coping High burden: not coping – high workload
and low capacity risk
Decreasing / low workload: No burden:
coping
Burden: not coping –low capacity risk
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tioners. Examples include:
 knowing what is happening and why: confidence
in services reduces worry when people can rely on
them (OP CMO 17);
 having information: when informed about complex
medications and regimes, people feel in control,
making these processes routine and less likely to be
forgotten (OP CMO 04);
 minimising change: practitioner trust and
consistency reduces worry because older people and
carers feel understood and supported (OP CMO 12);
 minimising transitions: service and practitioner
stability helps practitioners and family carers to cope
because they are less distracted by fragmentation (P
CMO 14); and
 being engaged: when family carer’s role,
responsibilities and needs are not recognised and
systems are unclear, and they are expected to cope,
they feel undervalued and unsupported (C CMO
13).Identifying five burdens
In order to consolidate the findings above with a specific
focus on the impacts of medication management on
older people, further analyses were performed and five
burdens were identified from the analysis described
above (see Additional File 4 for exemplar quotes illus-
trating these burdens):
 ambiguity burden when the purpose, practice and
benefits of reviewing / reconciling medications
within medication management are not explained,
limiting this stage’s contribution to their health and
wellbeing. This aligns with ‘clarification’ work during
sense making;
 concealment burden due to a lack of information
that prevents older people and family carers from
understanding, personalising and using what they
want or need to know. This relates to ‘information’
work during sense making, contributing to how
people use knowledge to increase a sense of personal
efficacy, agency, control and coping; unfamiliarity burden from not seeing the same
practitioner consistently. This concerns relationships
and establishing foundations of mutual trust
through continuity. It also encompasses
unfamiliarity with changes to services and staffing in
organisations and systems that are in a state of flux,
such as from reorganisations and improvement
initiatives;
 fragmentation burden from being seen by several
practitioners working across separate services and
organisations, potentially limiting how older people
and family carers are understood and how their
complex and subtly changing needs are addressed.
This relates to a breakdown in face-to-face relation-
ships and communication, including inter-
practitioner collaboration, within and between ser-
vices and organisations, exacerbated by boundaries
and transitions; and
 exclusion burden when older people and family
carers are not recognised for their experience and
expertise, nor fully or effectively engaged in
decisions that affect their health and care. This
concerns action, and the lack of collaboration
through shared decision making around common
goals.
Burden identification and mitigation were considered
to be fundamental aspects of the experience and practice
of medication management.MEMORABLE: theoretical framework
The theoretical framework, Fig. 3, is the key output from
MEMORABLE. It provides a high level overview and
summary of how medication management impacts on
those involved that draws together the findings from the
above analysis process, highlighting:
 the focus on participants in medication
management: primarily older people living with
multi-morbidity and polypharmacy, but also family
carers and practitioners;
 the centrality of burden (workload and capacity)
and types of burden, coping and risk to
medication management; and
Fig. 3 MEMORABLE’s theoretical framework for medication management: understanding burden
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involved in and the importance of the interplay
between sense making, action, reflection /
monitoring and relationships that are foundational
to the work done and outcomes achieved.
The framework also prompts the reader to consider
the potential differences in duration of stages, such as
Stage 2 typically less than 10 min; Stage 5 perhaps up to
an hour; and Stage 4, several months, if diagnoses and
medications remain stable.
Discussion
Summary of findings
By adopting a realist approach and progressively focus-
ing the synthesis of rich data from evidence andexperiential accounts, MEMORABLE has addressed the
complexity of the topic, medicine management. The
findings have enhanced the understanding of the scope
of medication management by establishing a five stage,
four step, three loop medication management process.
The more detailed analysis of one stage (Stage 5) identified
five specific burdens, and generating an evidence and
experience-based programme theory set out as a theoret-
ical framework to explain the real world complexity of
medication management for and with older people.
Implications of the research findings
MEMORABLE was conceived as the first study of
medication management in older people to use realist
methodology. It established that medication manage-
ment is neither ‘one thing’ nor simply cause and effect.
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stages, steps and loops, and at multiple levels, in which
older people, family carers and health and care practi-
tioners engage, in various ways and at various times.
MEMORABLE acknowledges an apparent tension be-
tween different participants’ goals and outcomes.
MEMORABLE has highlighted the importance of indi-
vidual experience and interpersonal work that directly
addresses burden mitigation, through workload, capacity,
coping and risk, involving information, clarification and
support, transacted through effective shared decision
making, and based on relationship continuity and mu-
tual trust.
MEMORABLE reaffirms the place of older people and
their experience at the centre of medication management,
acknowledging their individuality, ingenuity, sense of pur-
pose and routine-reliance in an attempt to cope with the
burden of living with multi-morbidity and polypharmacy.
One of the key, perhaps, the key finding from MEMOR-
ABLE was that managing medication, particularly com-
plex regimens, can be very burdensome, impacting on the
day-to-day lives of older people and family carers. These
burdens are often hidden from practitioners. Practitioners
need to make a conscious effort to be aware of the bur-
dens associated with medication management and should
work with older people and their carers to reduce them.
As a practical example, when a new treatment is consid-
ered (Stage 2) practitioners should consider the burden of
managing the medication (Stages 1, 3 and 4) just as they
consider the side effect potential.
MEMORABLE has highlighted two key practice gaps
and generated evidence for addressing burdens: provid-
ing information to reflect the individual experience of
managing multiple diagnoses and medications in this
population; and, identifying those at greatest risk of not
coping with the burden of medication management who
would benefit from timely referral for additional help
and support. Both have the potential to improve medica-
tion management, outcomes and satisfaction, benefitting
those involved and health and care services.Strengths and limitations of the study
Strengths
Benefitting from realist expertise amongst the re-
searchers, MEMORABLE has addressed the complexity
of medication management using a credible and appro-
priate methodology. It has demonstrated the advantages
of combining data from a realist review with a realist
evaluation to significantly strengthen reasoning about
causality. Indeed the key strength and novelty of MEM-
ORABLE is the thorough inclusion of the views of older
people and their family carers on the challenges associ-
ated with medication management.This approach proved invaluable in overcoming the
limited data on causation from existing documents on
this topic.
Limitations
Grappling with the complexity of the topic was time
consuming. The researchers were generating a causal
understanding of the topic as the interviews began. It
was not possible to refine the interview schedule to
focus on the evolving programme theory, and more spe-
cifically, Stage 5 and burden.
Also, detailed analysis was confined to a single stage of
the medication management process, in line with priori-
tisation of programme theory which characterises realist
approaches, rather than across all five stages.
Future research directions
Two possible avenues of the development of future in-
terventions have been identified by the researchers,
noted in Implications, above. The researchers are plan-
ning to take these forward, using collaborative, research-
into-practice approaches. However, they recognise the
challenges of introducing and embedding more individu-
ally responsive, evidence and experience-based ap-
proaches to medication management in services,
organisations and systems that are stridently
performance-driven and change-fatigued.
MEMORABLE has highlighted the plight of informal
or family carers, clearly identifying the burden associated
with the lack of training and support they receive in
comparison with formal carers to carry out the same
medication management tasks. Further work in this area
is urgently needed.
Additionally, COVID-19 may increase the burden asso-
ciated with the practical aspects of medication manage-
ment and make it more challenging for older people and
their family carers to obtain appropriate support. Further
research on the impact of COVID-19 is required.
Acknowledging the inherent complexity, future re-
search on burdens in medication management should
also further investigate how different contextual factors
in different patient, family carer and practitioner groups
impact day-to-day medication management.
Finally, having established a programme theory for
Stage 5, the researchers are seeking to transfer this the-
ory to all stages of medication management. A research
proposal for this important realist inquiry is being devel-
oped as a platform for further translational projects.
Comparison with existing literature
The researchers identified only a small number of arti-
cles on this topic, none using an explanatory, realist ap-
proach. Detailed data on outcomes was lacking and few
papers explained the contributions of family carers or
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MEMORABLE offers a potentially significant explana-
tory realist approach to start to address these gaps.
MEMORABLE seeks to establish a nuanced understand-
ing of the concept of burden to add to the extensive lit-
erature on the topic. It also adds an applied, exemplar
study to the substantial body of work on Normalisation
Process Theory.
Conclusions
Medication management embodies complexity, charac-
terised by open, dynamic systems and processes, en-
gaging diverse individuals, sometimes working alone and
occasionally together towards potentially conflicting out-
comes. Older people and family carers often find the
complexity and burdens associated with medication
challenging to manage on a day-to-day basis. Practi-
tioners need to be aware of this potential challenge asso-
ciated with medication management and its impact on
daily lives, and work with older people and family carers
to reduce the burdens associated with medication
management.
Medication management research can understand this
complexity by combining explanatory accounts from
multiple perspectives with causally structured evidence
in ways that are theory-informed and theory-generating.
Centred on the day-to-day experiences and challenges
facing all those involved, such a real world approach is
vital to developing ways to improve this critical aspect of
health and care.
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